Listed

Phathom Pharmaceuticals, Inc.

PHATNasdaqCIK 1783183HealthcareFiscal year ends Dec 31

Reports and events: 156 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Phathom Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2024-05-0908:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-24-134793
2024-04-1216:03 ETDEF 14AProxy statementPeriod 2024-05-230000950170-24-044015
2024-03-0716:01 ET10-KAnnual reportPeriod 2023-12-310000950170-24-027910
2024-03-0708:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-24-061512
2024-02-1308:05 ET8-K8.01 Other events0001193125-24-032946
2023-12-1516:05 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-23-296630
2023-12-1408:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001193125-23-294942
2023-12-0608:05 ET8-K8.01 Other events0001193125-23-289582
2023-11-2808:06 ET8-K8.01 Other events0001193125-23-283719
2023-11-0908:05 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-061554
2023-11-0908:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-274082
2023-11-0117:06 ET8-K8.01 Other events0001193125-23-268319
2023-10-3008:05 ET8-K8.01 Other events0001193125-23-265692
2023-09-2608:05 ET8-K8.01 Other events0001193125-23-241941
2023-08-2108:07 ET8-K8.01 Other events0001193125-23-216611
2023-08-1016:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-209005
2023-08-1008:06 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-040977
2023-07-1716:04 ET8-K5.02 Departure or appointment of officers or directors0001193125-23-188097
2023-06-1509:05 ET8-K8.01 Other events0001193125-23-167476
2023-06-1208:05 ET8-K8.01 Other events0001193125-23-164930
2023-05-3017:16 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-156713
2023-05-2617:29 ETSC 13D/AOwnership report, active investor, amended0001193125-23-155579
2023-05-2416:14 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-152946
2023-05-2316:03 ET8-K8.01 Other events0001193125-23-151785
2023-05-1008:19 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-020109
2023-05-1008:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-140078
2023-05-0516:13 ETSC 13D/AOwnership report, active investor, amended0001193125-23-137114
2023-04-1316:03 ETDEF 14AProxy statementPeriod 2023-05-250000950170-23-012704
2023-04-0408:06 ET8-K8.01 Other events0001193125-23-090354
2023-02-2808:06 ET10-KAnnual reportPeriod 2022-12-310000950170-23-004875
2023-02-2808:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-052344
2023-02-0916:06 ET8-K8.01 Other events0001193125-23-030011
2023-01-0906:07 ET8-K8.01 Other events0001193125-23-004049
2023-01-0316:09 ET8-K8.01 Other events0001193125-23-000749
2022-11-0908:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-280741
2022-11-0917:56 ET10-Q/AQuarterly report, amendedPeriod 2022-09-300000950170-22-023372
2022-11-0815:31 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-023160
2022-11-0108:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-274514
2022-10-2408:05 ET8-K8.01 Other events0001193125-22-267152
2022-09-2908:01 ET8-K1.01 Entry into a material agreement0001193125-22-253755
2022-09-2616:00 ETSC 13D/AOwnership report, active investor, amended0001193125-22-251241
2022-09-2608:06 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-250665
2022-08-1115:55 ETSC 13D/AOwnership report, active investor, amended0001193125-22-218481
2022-08-0416:06 ET8-K1.01 Entry into a material agreement0001193125-22-212499
2022-08-0208:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-209506
2022-08-0208:16 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-013743
2022-05-2716:06 ET8-K5.07 Shareholder vote results; 8.01 Other events0001193125-22-162331
2022-05-2508:05 ET8-K8.01 Other events0001193125-22-159128
2022-05-1008:16 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-008741
2022-05-1008:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-145742

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:04 ET. Listed shows no prices and gives no investment advice.